Inflammatory syndrome experiments related with COVID-19

According to the first SARS-CoV-2 pandemic reports that signs and symptoms were identified less commonly among pediatric patients than adults. The multisystem inflammatory syndrome in children (MISC), which is linked to COVID -19, was first identified in April. Fever, presented in two or more organ systems at the same time, altered inflammatory criteria, and experimental or epidemiological proof of SARSCoV-2 infection are all symptoms of MIS-C. Kawasaki disorder, toxic shock syndrome, and secondary hemophagocytic lymph histiocytosis syndrome/macrophage activation syndrome all have certain clinical elements in common with MIS-C. The clinical features of seven cases of MIS-C handled in the Republic of Moldova are described in this study.